ABL-specific tyrosine kinase inhibitor, STI571 in vitro, affects Ph-positive acute lymphoblastic leukemia and chronic myelogenous leukemia in blastic crisis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples